Friday April 3, 2015 0 comments
DENVER - The Colorado Bioscience Institute, a partner organization to the Colorado BioScience Association (CBSA), is tackling the biggest challenges that bioscience entrepreneurs face with a learning and leadership program designed specifically for early-stage bioscience companies.
The Institute's Executive Leadership Program class of 2015 now underway includes 12 entrepreneurs from emerging Colorado companies. They represent CoramiR Diagnostics and Mosaic Biosciences; Ocugen Inc.; Biodesix; Surefire Medical; OptiEnz Sensors; AlloSource; GlobeImmune; CSU (Boettcher Investigators Program); VetDC; Precision Biopsy; and CBSA.
Fellow entrepreneurs and recognized leaders in bioscience provide advice and training on specific skills unique to early-stage ventures. The program also provides the kind of peer support most leaders say they lack.
"Colorado continues to receive national recognition as a top place for entrepreneurs to start a business," said April Giles, CBSI president and CEO.
"For bioscience entrepreneurs, CBSI focuses on creating a thriving biobusiness community with access to needed talent and community support. Our executive leadership program provides the training and networks our bioscience entrepreneurs need to build successful companies."
Bioscience leaders lending their expertise to the 2015 program include Gino DiSciullo, Great Lakes Pharmaceuticals CEO; Larry Gold, Somalogic founder and chair; Ginger Graham, Two Trees Consulting president and CEO; Bev Huss, Qool Therapeutics president and CEO; and Gary Richardson, Richardson International.
For more information, visit here.